Back

A direct comparison of non-invasive blood markers of liver fibrosis as associates of cardiovascular risk. The Athens cardiometabolic registry

30 August 2024 (08:00 - 17:30)
Organised by: Logo
Congress Presentation Part of: Novel biomarkers for cardiovascular risk prediction Biomarkers ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Doctor Stavros Athanasopoulos

(Greece)

5 More presentations in this session

Presentation thumbnail
Serum amyloid A-low-density-lipoprotein complex and cause-specific mortality in patients with suspected or known coronary artery disease: The ANOX Study
Doctor M. Suzuki (Wako, Saitama, JP)
Abstract Slides Video
Presentation thumbnail
Associations between neutrophil-percentage-to-albumin ratio level and all-cause mortality and cardiovascular disease-cause mortality in general population: evidence from nhanes 1999-2010
Doctor Z. Qiu (Beijing, CN)
Abstract Slides Video
Presentation thumbnail
Remnant cholesterol is associated with platelet reactivity for patients with coronary artery disease underwent percutaneous coronary intervention
Mrs J. Li (Beijing, CN)
Abstract Slides Video
Presentation thumbnail
Cystatin C predicts cardiovascular events in patients with coronary artery disease both among patients with and among those without type 2 diabetes
Associate Professor A. Vonbank (Feldkirch, AT) Doctor A. Mader (Feldkirch, AT)
Abstract Slides Video
Presentation thumbnail
Novel insights of phenylalanine in Metabolic dysfunction-Associated Steatotic Liver Disease (MASLD) and cardiovascular complications
Doctor J. Liu (Oxford, GB)
Abstract Slides Video

Access the full session

Session thumbnail
Novel biomarkers for cardiovascular risk prediction
Video

The Event

Event poster

ESC Congress 2024

30 August - 2 September 2024
You may be interested in
thumbnail
Congress Presentation
Advancements and challenges in cardiovascular risk stratification: an overview of cardiac biomarkers
thumbnail
Webinar
Biomarkers of clinical utility in cardiovascular disease
thumbnail
Congress Session
Challenges and innovations in cardiovascular risk stratification with cardiac biomarkers

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources